Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
---|
02/27/2013 | CN102940685A Lanceleaf anisetree extract and external transdermal absorption agent containing lanceleaf anisetree extract |
02/27/2013 | CN102940684A Traditional Chinese medicine composition containing illicium henryi and preparation method thereof |
02/27/2013 | CN102940648A Bee propolis soft capsule and manufacturing process thereof |
02/27/2013 | CN102940644A Drug for treating nasosinusitis |
02/27/2013 | CN102940642A Aspirin eugenol ester-paracetamol compound sustained-release tablet |
02/27/2013 | CN102940632A Application of FK506-A compound in preparation of immunosuppressant |
02/27/2013 | CN102940630A Medicinal composition containing temsirolimus and preparation method of medicinal composition |
02/27/2013 | CN102940618A Loxoprofen organic amine salt transdermal patch and preparation method thereof |
02/27/2013 | CN102940614A Method for preparing bulleyaconitine-containing tablets |
02/27/2013 | CN102940608A Tripterine controlled-release solid dispersion |
02/27/2013 | CN102302604B Traditional Chinese medicine (TCM) for treating arthritis |
02/27/2013 | CN102283909B Medicament for treating anorectal diseases, adiposity, hyperlipemia and acnes and application thereof |
02/27/2013 | CN102204967B Preparation method for safflower care-free tablet |
02/27/2013 | CN102153619B Small molecular weight glycopeptide extracted from stiff silkworm as well as extraction separation method and application thereof |
02/27/2013 | CN101959884B Derivatives of 6-heterocyclic-imidazo[l,2-alpha]pyrroine-2-carboxamides, preparation thereof and therapeutic application thereof |
02/27/2013 | CN101732467B Application of Chinese medicinal composition in preparation of medicament for treating purulent pleurisy |
02/27/2013 | CN101687851B Organic compounds |
02/27/2013 | CN101511800B Triazolyl phenyl benzenesulfonamides |
02/26/2013 | US8383155 Swellable dosage form comprising gellan gum |
02/26/2013 | US8383153 Poly(amidoamine) oligomer hydrogel for drug delivery and drug carrier using the same |
02/26/2013 | CA2543497C Controlled release analgesic suspensions |
02/21/2013 | WO2013026025A1 Cyclohexyl azetidine derivatives as jak inhibitors |
02/21/2013 | WO2013025883A1 Heteroaryl sodium channel inhibitors |
02/21/2013 | WO2013025733A1 Lysophosphatidic acid receptor antagonists |
02/21/2013 | WO2013025538A2 Compositions, methods and uses of alpha 1-antitrypsin for early intervention in bone marrow transplantation and treatment of graft versus host disease |
02/21/2013 | WO2013025474A2 Compositions and methods for regulating neutrophil movement and neutrophil numbers in a body region |
02/21/2013 | WO2013024960A1 Medical composition containing stauntonia hexaphylla extract |
02/21/2013 | WO2013024898A1 Heterocyclic derivative and pharmaceutical drug |
02/21/2013 | WO2013024291A2 Therapeutically active fused pyrimidine derivatives |
02/21/2013 | WO2013024104A1 4-(8-methoxy-1-((1-methoxypropan-2-yl)-2-(tetrahydro-2h-pyran-4-yl)-1 h-imidazo[4,5-c]quinolin-7-yl)-3,5-dimethylisoxazole and its use as bromodomain inhibitor |
02/21/2013 | WO2013024067A1 Use of antioxidants for improving animal health |
02/21/2013 | WO2013023439A1 Salt and polymorph of pyrazolopyrimidinone compound and drug composition, preparation method and use thereof |
02/21/2013 | WO2012177660A3 Leukotoxin e/d as a new anti-inflammatory agent and microbicide |
02/21/2013 | WO2012170839A3 Treatment of neuroinflammatory disease with selective cox1 inhibitors |
02/21/2013 | WO2012154944A9 Methods of treating autophagy-associated disorders and related pharmaceutical compositions, diagnostics, screening techniques and kits |
02/21/2013 | WO2012149186A9 Novel bisaminoquinoline compounds, pharmaceutical compositions prepared therefrom and their use |
02/21/2013 | WO2011101069A3 1, 8 -naphthyridines as kinase inhibitors |
02/21/2013 | US20130046240 Bepotastine compositions |
02/21/2013 | US20130046020 Eicosapentaenoic acid concentrate |
02/21/2013 | US20130046019 Methods of Treatment Using 3-Bromopyruvate and Other Selective Inhibitors of ATP Production |
02/21/2013 | US20130046015 Therapeutic Inhibition of Granulocyte Function in Demyelinating Disease |
02/21/2013 | US20130046013 Salicylate fatty acid derivatives |
02/21/2013 | US20130046012 New compounds, synthesis and use thereof in the treatment of pain |
02/21/2013 | US20130046007 Selective reduction of allelic variants |
02/21/2013 | US20130046004 Oxygen-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals |
02/21/2013 | US20130045997 Pirfenidone therapy and inducers of of cytochrome p450 |
02/21/2013 | US20130045986 Novel compounds as modulators of gpr-119 |
02/21/2013 | US20130045975 Bicyclic heteroaryl inhibitors of pde4 |
02/21/2013 | US20130045973 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
02/21/2013 | US20130045967 COMPOUNDS FOR MODULATING INTEGRIN CDIIb/CDI8 |
02/21/2013 | US20130045965 Inhibitors of bruton's tyrosine kinase |
02/21/2013 | US20130045964 Mandelamide heterocyclic compounds |
02/21/2013 | US20130045963 Cyclohexyl Azetidine Derivatives as JAK Inhibitors |
02/21/2013 | US20130045956 Preventive and/or therapeutic agent of hand-foot syndrome |
02/21/2013 | US20130045948 Azocyclic inhibitors of fatty acid amide hydrolase |
02/21/2013 | US20130045945 Treatment of Arthritis and Other Musculoskeletal Disorders With Crosslinked Hyaluronic Acid |
02/21/2013 | US20130045939 Fatty acid macrolide derivatives and their uses |
02/21/2013 | US20130045932 Retinoid topical compositions and methods for treating skin conditions |
02/21/2013 | US20130045930 Crystalline forms of the mono-sodium salt of d-isoglutamyl-d-tryptophan |
02/21/2013 | US20130045925 Compositions for ameliorating cell proliferative disorders and methods of making and using them |
02/21/2013 | US20130045919 Sustained-Release Formulations Comprising Crystals, Macromolecular Gels, and Particulate Suspensions of Biologic Agents |
02/21/2013 | US20130045914 Biaryl spiroaminooxazoline analogues as alpha2c adrenergic receptor modulators |
02/21/2013 | US20130045520 Double-stranded oligonucleotides |
02/21/2013 | US20130045279 Analgesic and anti-inflammatory composition |
02/21/2013 | US20130045266 Method for preparing polymeric biomaterials having immobilized drug delivery system comprising bioactive molecules loaded particle carrier |
02/21/2013 | US20130045243 NANOGENOMICS FOR MEDICINE: siRNA ENGINEERING |
02/21/2013 | US20130045236 Diagnostic and therapeutic uses of soluble fc-epsilon receptor i for ige-mediated disorders |
02/21/2013 | US20130045219 Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind cd154 and uses thereof |
02/21/2013 | US20130045212 Biological Materials and Uses Thereof |
02/21/2013 | US20130045186 Method of Detecting and/or Identifying Adeno-Associated Virus (AAV) Sequences and Isolating Novel Sequences Identified Thereby |
02/21/2013 | US20130045183 Boswellia oil, its fractions and compositions for enhancing brain function |
02/21/2013 | US20130045174 Use of indole compounds as a cosmetic |
02/21/2013 | US20130045169 Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity |
02/21/2013 | US20130045165 4-fluoro-4-arylpiperdin-1-yl derivatives as mu opioid function moderators |
02/21/2013 | CA2845625A1 Medical composition comprising stauntonia hexaphylla extract |
02/21/2013 | CA2845536A1 Anti-b7-h4 antibodies and their uses |
02/21/2013 | CA2845250A1 Salt and polymorph of pyrazolopyrimidinone compound, and pharmaceutical composition containing the same, preparation method and use thereof |
02/21/2013 | CA2844982A1 Lysophosphatidic acid receptor antagonists |
02/21/2013 | CA2844799A1 Heteroaryl sodium channel inhibitors |
02/21/2013 | CA2844794A1 Heterocyclic derivative and pharmaceutical |
02/21/2013 | CA2843537A1 4-(8-methoxy-1-((1-methoxypropan-2-yl)-2-(tetrahydro-2h-pyran-4-yl)-1 h-imidazo [4,5-c] quinolin-7-yl)-3,5-dimethylisoxazole and its use as bromodomain inhibitor |
02/20/2013 | EP2559694A2 Azaindoles useful as inhibitors of Janus kinases |
02/20/2013 | EP2558503A1 Compositions and methods for brain delivery of analgesic peptides |
02/20/2013 | EP2558500A1 Proteins that bind pi16 and uses thereof |
02/20/2013 | EP2558474A1 2, 4-pyrimidinediamine compounds and prodrugs thereof and their uses |
02/20/2013 | EP2558468A1 5, 7-substituted-imidazo [1, 2-c]pyrimidines as inhibitors of jak kinases |
02/20/2013 | EP2558463A1 Fused derivatives as i3 inhibitors |
02/20/2013 | EP2558101A1 Topical treatments for pain |
02/20/2013 | EP2558099A2 Kinase inhibitors |
02/20/2013 | EP2557924A1 Dermal pharmaceutical compositions of 1-methyl-2',6'-pipecoloxylidide and method of use |
02/20/2013 | CN102939305A Antibodies to cd122 |
02/20/2013 | CN102939303A Tetravalent cd47-antibody constant region fusion protein for use in therapy |
02/20/2013 | CN102939109A Combination of drugs with protein-binding prodrugs |
02/20/2013 | CN102939093A Instant thickener comprising probiotics for hot or cold foods and beverages to be administered to dysphagic patients |
02/20/2013 | CN102939087A Novel indazole derivative or salt thereof, manufacturing intermediate therefor, antioxidant using same, and use for an indazole derivative or salt thereof |
02/20/2013 | CN102936250A 稠合双环mTOR抑制剂 Fused bicyclic inhibitors of mTOR |
02/20/2013 | CN102936212A Guanylhydrazone compounds, compositions, methods of making and using |
02/20/2013 | CN102935245A Wind-cold dispelling incense |
02/20/2013 | CN102935235A Preparation method of modified casein drug-carrying controlled-release thin film |
02/20/2013 | CN102935217A Drug for treating traumatic injury |